目前的使用和未来的机遇 - 一个APV课程关于制造,包装,表征和使用的minitablets
Susanne Page1, Timo Rode2, Jörg Breitkreutz3
1Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Grenzacherstr. 124, CH-4070 Basel, Switzerland.
概括
本课程探讨了微型药片的制造,包装,表征和医疗应用,强调了当前的用途和制药发展的未来机会.
科学领域:
- 制药技术 制药技术 制药技术
- 药物输送系统是药物输送系统.
背景情况:
- 迷你盘在药物输送方面具有优势,特别是对于特定患者群体.
- 制造技术的进步正在扩大微型机械的潜力.
研究的目的:
- 为提供由APV和Fette Compacting GmbH.组织的关于微型机的课程的概述.
- 讨论小平板技术的当前应用和未来前景.
- 涵盖包括制造,包装,表征和医疗用途在内的关键方面.
主要方法:
- 内容基于30名参与者参加的课程和研讨会.
- 活动期间提出和讨论的主题构成了本概述的基础.
- 从演讲和互动会议中收集了信息.
主要成果:
- 该课程涵盖了迷你桌子的整个生命周期,从生产到临床应用.
- 讨论强调了迷你平板技术的既定和新兴趋势.
- 专家们分享了关于优化微型平板电脑制造和表征的见解.
结论:
- 迷你药片在制药开发中代表着一个重要的创新领域.
- 进一步探索制造,包装和医疗应用是有必要的.
- 像APV这样的行业和学术机构之间的合作对于推进药物输送技术至关重要.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
834
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
834
Biopharmaceutical Factors Influencing Drug Product Design: Overview
547
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
547
In Vitro Drug Release Testing: Overview, Development and Validation
593
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
593
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
420
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
420
Overview of Minitab
1.1K
Minitab is a statistical software package designed for data analysis. With its origins in the 1970s and development at Pennsylvania State University, Minitab has grown significantly in its capabilities and applications. It plays a crucial role in quality management projects, especially in Six Sigma initiatives, by offering tools for process improvement and statistical analysis. Minitab's significance lies in its user-friendly interface, making complex statistical analysis accessible to...
1.1K


